November 3, 2025 · Form 4 insider transaction
Wilson Martin bought 100,000 shares of Rocket Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.; Represent RSUs that convert to common stock on a one-for-one basis. The RSUs will become fully vested on November 3, 2026.